Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality
Paola Sanese(Gastroenterology Hospital "Saverio de Bellis"), Cristiano Simone(Gastroenterology Hospital "Saverio de Bellis")
Cited by 25
Related Papers
A SMYD3 Small‐Molecule Inhibitor Impairing Cancer Cell Growth
|Journal of Cellular Physiology|2015|128
Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy
|Cell Death and Disease|2018|55
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance
|Journal of Experimental & Clinical Cancer Research|2024|8
Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis
|Signal Transduction and Targeted Therapy|2025|7